The effect of bright light therapy on depressive symptoms in adults with intellectual disabilities: Results of a multicentre randomized controlled trial
- PMID: 32583931
- PMCID: PMC7687277
- DOI: 10.1111/jar.12770
The effect of bright light therapy on depressive symptoms in adults with intellectual disabilities: Results of a multicentre randomized controlled trial
Abstract
Background: Although a large number of adults with intellectual disabilities have depressive symptoms, non-pharmacological treatments are scarce. The present authors investigated whether bright light therapy (BLT) is effective in decreasing depressive symptoms compared to care as usual.
Methods: This multicentre randomized controlled trial consisted of three study groups (10,000 lux BLT, dim light BLT and a no-BLT group). Participants received BLT for 30 min in the morning (14 consecutive days), additional to their regular care. Primary outcome was as follows: depressive symptoms measured with the ADAMS Depressive Mood subscale 1 week after the end of BLT (same time period in the no-BLT group).
Results: Forty-one participants were included in our trial. In both BLT groups, a significant decrease in depressive symptoms was seen. No significant differences were found between 10,000 lux BLT and no-BLT (p = .199) and no significant differences between dim light BLT and no-BLT (p = .451). A minimum amount of side effects and no adverse events were reported.
Conclusions: In both BLT interventions, a decrease in depressive symptoms was seen. With 10,000 lux BLT, depressive symptoms decreased even below the clinical cut-off point, which makes BLT a promising intervention for clinical practice.
Keywords: bright light therapy; depressive symptoms; intellectual disabilities; randomized controlled trial.
© 2020 The Authors. Journal of Applied Research in Intellectual Disabilities published by John Wiley & Sons Ltd.
Conflict of interest statement
PB, DF, HH and PH report grands from the Dioraphte Foundation and Foundation for Support VCVGZ for the conduct of the study. PB, DF, HH and PH report funding from three care provider centres of the HA‐ID Consort (Abrona, Amarant and Ipse de Bruggen) during the conduct of the study.
Figures
References
-
- Altabet, S. , Neumann, J. K. , & Watson‐Johnston, S. (2002). Light therapy as a treatment of sleep cycle problems and depression. Mental Health Aspects of Developmental Disabilities, 5(1), 1–6.
-
- Aman, M. G. , Singh, N. N. , Stewart, A. W. , & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485–491. - PubMed
-
- Boutron, I. , Altman, D. G. , Moher, D. , Schulz, K. F. , & Ravaud, P. (2017). CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Annals of Internal Medicine, 167(1), 40–47. 10.7326/m17-0046 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
